Weekly Journal Scan: improved renal outcomes by semaglutide in patients with chronic kidney disease and type 2 diabetes in FLOW trial

被引：1
|
作者：
Pedicino, Daniela [1 ]
Volpe, Massimo [2 ,3 ]
机构：
[1] Fdn Policlin Univ A Gemelli IRCCS, Dept Cardiovasc Med, Largo A Gemelli 8, I-00168 Rome, Italy
[2] Sapienza Univ Rome, Dept Clin & Mol Med, Via Grottarossa 1035, Rome, Italy
[3] IRCCS San Raffaele Roma, Via Valcannuta 250, Rome, Italy
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷 / 38期
关键词：
GLP-1 RECEPTOR AGONISTS; MORTALITY;
D O I：
10.1093/eurheartj/ehae429
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3910 / 3911
页数：2
相关论文
共 50 条
  • [1] Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial
    Mahaffey, Kenneth W.
    Tuttle, Katherine R.
    Arici, Mustafa
    Baeres, Florian M. M.
    Bakris, George
    Charytan, David M.
    Cherney, David Z., I
    Chernin, Gil
    Correa-Rotter, Ricardo
    Gumprecht, Janusz
    Idorn, Thomas
    Pugliese, Giuseppe
    Rasmussen, Ida Kirstine Bull
    Rasmussen, Soren
    Rossing, Peter
    Sokareva, Ekaterina
    Mann, Johannes F. E.
    Perkovic, Vlado
    Pratley, Richard
    EUROPEAN HEART JOURNAL, 2024,
  • [2] BASELINE CHARACTERISTICS OF THE FLOW TRIAL POPULATION: KIDNEY OUTCOMES TRIAL WITH ONCE-WEEKLY SEMAGLUTIDE IN PEOPLE WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE
    Perkovic, Vlado
    Baeres, Florian
    Bakris, George
    Bosch-Traberg, Heidrun
    Idorn, Thomas
    Mahaffey, Kenneth
    Mann, Johannes
    Mersebach, Henriette
    Rossing, Peter
    Tuttle, Katherine
    Pratley, Richard
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I893 - I894
  • [3] The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease
    Rossing, Peter
    Baeres, Florian M. M.
    Bakris, George
    Bosch-Traberg, Heidrun
    Gislum, Mette
    Gough, Stephen C. L.
    Idorn, Thomas
    Lawson, Jack
    Mahaffey, Kenneth W.
    Mann, Johannes F. E.
    Mersebach, Henriette
    Perkovic, Vlado
    Tuttle, Katherine
    Pratley, Richard
    FLOW Steering Comm
    FLOW Trial Investigators
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 (09) : 2041 - 2051
  • [4] The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease
    Rossing, Peter
    Baeres, Florian M. M.
    Bakris, George
    Bosch-Traberg, Heidrun
    Gislum, Mette
    Gough, Stephen C. L.
    Idorn, Thomas
    Lawson, Jack
    Mahaffey, Kenneth W.
    Mann, Johannes F. E.
    Mersebach, Henriette
    Perkovic, Vlado
    Tuttle, Katherine
    Pratley, Richard
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 (04) : 724 - 724
  • [5] Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
    Perkovic, Vlado
    Tuttle, Katherine R.
    Rossing, Peter
    Mahaffey, Kenneth W.
    Mann, Johannes F. E.
    Bakris, George
    Baeres, Florian M. M.
    Idorn, Thomas
    Bosch-Traberg, Heidrun
    Lausvig, Nanna Leonora
    Pratley, Richard
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (02): : 109 - 121
  • [6] Effect of semaglutide on chronic kidney disease in patients with type 2 diabetes: An analysis of the FLOW study
    Feldkamp, Thorsten
    NEPHROLOGIE, 2024, 19 (06): : 367 - 369
  • [7] Semaglutide for Chronic Kidney Disease in Type 2 Diabetes
    Passos, Rogerio da Hora
    Narciso, Roberto Camargo
    da Silva, Arnaldo Alves
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (18): : 1757 - 1757
  • [8] Effects of Semaglutide on Heart Failure Outcomes in Diabetes and Chronic Disease in the FLOW Trial
    Pratley, Richard E.
    Tuttle, Katherine R.
    Rossing, Peter
    Rasmussen, Soren
    Perkovic, Vlado
    Nielsen, Olav Wendelboe
    Mann, Johannes F. E.
    MacIsaac, Richard J.
    Kosiborod, Mikhail N.
    Kamenov, Zdravko
    Idorn, Thomas
    Hansen, Marco Bo
    Hadjadj, Samy
    Bakris, George
    Baeres, Florian M. M.
    Mahaffey, Kenneth W.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (17) : 1615 - 1628
  • [9] Benefits of Semaglutide on Chronic Kidney Disease Outcomes by Cardiovascular Status or Risk in the FLOW trial
    Tuttle, Katherine
    Bakris, George
    Bang, Casper
    Bax, Willem
    Belmar, Nicolas
    Brown, Paul
    Cherney, David
    Chernin, Gil
    Lim, Soo Kun
    Mann, Johannes
    Perkovic, Vlado
    Pratley, Richard
    Ridker, Paul
    Rossing, Peter
    Schmieder, Roland
    Shamkhalova, Minara S.
    Sreenivasamurthy, L.
    Mahaffey, Kenneth
    CIRCULATION, 2024, 150 (25) : E746 - E746
  • [10] Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial
    Mann, Johannes F. E.
    Rossing, Peter
    Bakris, George
    Belmar, Nicolas
    Bosch-Traberg, Heidrun
    Busch, Robert
    Charytan, David M.
    Hadjadj, Samy
    Gillard, Pieter
    Gorriz, Jose Luis
    Idorn, Thomas
    Ji, Linong
    Mahaffey, Kenneth W.
    Perkovic, Vlado
    Rasmussen, Soren
    Schmieder, Roland E.
    Pratley, Richard E.
    Tuttle, Katherine R.
    NATURE MEDICINE, 2024, 30 (10) : 2849 - 2856
12345